InBrain Neuroelectronics wins FDA breakthrough nod for intelligent network modulation system
InBrain Neuroelectronics announced today that it received FDA breakthrough device designation for its intelligent network modulation system.
The breakthrough nod covers the graphene-neural platform as an adjunctive therapy for treating Parkinson’s disease.
